The drug Hepabene in the therapy of hepatobiliary system diseases
We presented data for many studies on the therapeutic efficacy of Hepabene having hepatoprotective, choleretic and spasmolytic properties, in patients with hepatobiliary system diseases. Positive properties of the drug are determined by the qualities of its component plants - Silybum marianum fruit extract and Fumaria officinalis herbs extract. The clinical trials data analyses confirmed the Hepabene effectiveness in the treatment of hepatobiliary system diseases and allowed us to formulate a list of indications for this drug administration. They are all kinds of biliary dyskinesia, chronic liver disease, including steatosis and toxic injury. We highlight the importance of Gepabene administration in patients with liver steatosis caused by metabolic syndrome and type 2 diabetes mellitus.

Keywords: Gepabene, fumarin, silibinin, flavonoids, hepatoprotectors